Welcome to LookChem.com Sign In|Join Free


  • or


Post Buying Request

118-92-3 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

118-92-3 Usage

Safety Profile

Moderately toxic by ingestion andintraperitoneal routes. Experimental reproductive effects.Human mutation data reported. Questionable carcinogenwith experimental tumorigenic data. Combustible. Whenheated to decomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 118-92-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 118-92:
53 % 10 = 3
So 118-92-3 is a valid CAS Registry Number.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017


1.1 GHS Product identifier

Product name anthranilic acid

1.2 Other means of identification

Product number -
Other names 2-amino-benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:118-92-3 SDS

118-92-3Related news

Rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process: Formation of 2-Aminobenzoic acid (cas 118-92-3) nanoparticle09/01/2019

A high solubility in supercritical fluid is desired for performing rapid expansion of supercritical solutions (RESS) to produce particles. Unfortunately, extremely low solubility of polar compounds in supercritical CO2 makes RESS unviable for commercial applications. Liquid cosolvents can improv...detailed

Notes & TipsDetection of chitinase activity by 2-Aminobenzoic acid (cas 118-92-3) labeling of chito-oligosaccharides08/31/2019

Chitinases are hydrolases capable of hydrolyzing the abundant natural polysaccharide chitin. Next to artificial fluorescent substrates, more physiological chito-oligomers are commonly used in chitinase assays. Analysis of chito-oligosaccharides products is generally accomplished by UV detection....detailed

The use of the 2-Aminobenzoic acid (cas 118-92-3) tag for oligosaccharide gel electrophoresis08/29/2019

Gel electrophoresis of fluorophore labeled saccharides provides a rapid and reliable method to screen enzymatic and/or chemical treatments of polysaccharides and glycoconjugates, as well as a sensitive and efficient microscale method to separate and purify oligosaccharides for further analysis. ...detailed

Research ArticlePharmaceutical BiotechnologySimple and Robust N-Glycan Analysis Based on Improved 2-Aminobenzoic acid (cas 118-92-3) Labeling for Recombinant Therapeutic Glycoproteins08/27/2019

N-glycans of therapeutic glycoproteins are critical quality attributes that should be monitored throughout all stages of biopharmaceutical development. To reduce both the time for sample preparation and the variations in analytical results, we have developed an N-glycan analysis method that incl...detailed

Direct oxidative cascade cyclisation of 2-Aminobenzoic acid (cas 118-92-3) and arylaldehydes to aryl 4H-3,1-benzoxazin-4-ones with oxone08/26/2019

This paper presents a methodology of oxidative cascade cyclisation of 2-aminobenzoic acids and arylaldehyde using I2 as a catalyst and an environmentally benign oxidant oxone. This method displays facile access to a diverse range of substituted aryl 4H-3,1-benzoxazin-4-ones. This synthetic metho...detailed

118-92-3Relevant articles and documents

Synthesis of oxazolidinones from N-aryl-carbamate and epichlorohydrin under mild conditions

Buscemi, Silvestre,Insuasty, Braulio,Marzullo, Paola,Moreno, Leydi Marcela,Piccionello, Antonio Palumbo

supporting information, p. 140 - 155 (2022/03/27)

The reaction conditions for an enantiospecific synthesis of various N-aryl-oxazolidinones from N-aryl-carbamates and (R) or (S) epichlorohydrin were optimized. The N-aryl-oxazolidinones were applied to the synthesis of compounds of biological interest such as DuP 721, toloxatone and a linezolid analogue.

Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease

Yao, Hong,Uras, Giuseppe,Zhang, Pengfei,Xu, Shengtao,Yin, Ying,Liu, Jie,Qin, Shuai,Li, Xinuo,Allen, Stephanie,Bai, Renren,Gong, Qi,Zhang, Haiyan,Zhu, Zheying,Xu, Jinyi

supporting information, p. 7483 - 7506 (2021/06/28)

Based on a multitarget strategy, a series of novel tacrine-pyrimidone hybrids were identified for the potential treatment of Alzheimer's disease (AD). Biological evaluation results demonstrated that these hybrids exhibited significant inhibitory activities toward acetylcholinesterase (AChE) and glycogen synthase kinase 3 (GSK-3). The optimal compound 27g possessed excellent dual AChE/GSK-3 inhibition both in terms of potency and equilibrium (AChE: IC50 = 51.1 nM; GSK-3β: IC50 = 89.3 nM) and displayed significant amelioration on cognitive deficits in scopolamine-induced amnesia mice and efficient reduction against phosphorylation of tau protein on Ser-199 and Ser-396 sites in glyceraldehyde (GA)-stimulated differentiated SH-SY5Y cells. Furthermore, compound 27g exhibited eligible pharmacokinetic properties, good kinase selectivity, and moderate neuroprotection against GA-induced reduction in cell viability and neurite damage in SH-SY5Y-derived neurons. The multifunctional profiles of compound 27g suggest that it deserves further investigation as a promising lead for the prospective treatment of AD.

Benzoselenazolone compound and application thereof and bactericide


Paragraph 0090; 0119; 0120; 0122, (2021/01/24)

The invention relates to the field of antifungal drugs, and discloses a benzoselenazolone compound and application thereof and a bactericide, and the benzoselenazolone compound has a structural general formula shown in a formula (I). The benzoselenazolone compound provided by the invention can take candida albicans fructose-1, 6-diphosphate aldolase (Ca-FBA-II) as a target spot to inhibit the activity of the candida albicans fructose 1, 6-diphosphate aldolase (Ca-FBA-II), and has a good resistance effect on drug-resistant bacteria generated by taking cytochrome P450 as an action target.